Health
Early MS treatments impact relapses and brain scarring differently, but not disability
Headline as filed by Medical Xpress.
Compare coverage — 1 report
| Publisher | Headline | Summary | Published | Detected | Delay | Source | Status |
|---|---|---|---|---|---|---|---|
| Medical Xpress | Early MS treatments impact relapses and brain scarring differently, but not disability |
Therapy targeting the immune system's B cells might offer better odds against relapses in the early stages of multiple sclerosis (MS), a new study reports. People taking IV drugs that lower immune B-c |
0m | medicalxpress.com | First |
Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.